KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Labcorp Holdings (LH) EPS (Weighted Average and Diluted) (2016 - 2025)

Labcorp Holdings' EPS (Weighted Average and Diluted) history spans 17 years, with the latest figure at $1.98 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 15.79% year-over-year to $1.98; the TTM value through Dec 2025 reached $10.46, up 18.46%, while the annual FY2025 figure was $10.46, 18.33% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $1.98 at Labcorp Holdings, down from $3.12 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $7.82 in Q1 2021 and bottomed at -$2.3 in Q4 2023.
  • The 5-year median for EPS (Weighted Average and Diluted) is $2.6 (2024), against an average of $2.94.
  • The largest annual shift saw EPS (Weighted Average and Diluted) soared 339.14% in 2021 before it crashed 342.11% in 2023.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $3.89 in 2021, then plummeted by 75.58% to $0.95 in 2022, then crashed by 342.11% to -$2.3 in 2023, then skyrocketed by 174.35% to $1.71 in 2024, then rose by 15.79% to $1.98 in 2025.
  • Per Business Quant, the three most recent readings for LH's EPS (Weighted Average and Diluted) are $1.98 (Q4 2025), $3.12 (Q3 2025), and $2.84 (Q2 2025).